We know your time is precious so we've drilled down the three most important medtech stories from the past week. But feel free to click the headline to read beyond the blurb.Image by OpenClipart-Vectors on Pixabay
A major server outage rattled Dexcom customers – particularly parents of diabetic children – over the U.S. Thanksgiving holiday weekend. But most were not as mad about the technology glitch as they were about the company's lack of communication about the issue. Dexcom has since fixed the problem and promised to communicate better with customers going forward.
Vicarious Surgical is now the first to receive a breakthrough device designation from FDA for a robotically-assisted surgical device. What makes this new robot so special? Virtual reality.
ViewRay has signed a non-binding memorandum of understanding with both Elekta and Medtronic. Elekta has committed to invest capital for up to a 9.9% minority interest in ViewRay, and Medtronic has agreed to invest in a minority interest in the company. ViewRay and Elekta plan to advance the knowledge and use of MR-guided radiation therapy. ViewRay and Medtronic plan to explore the clinical benefits of the MRIdian MR-guided radiation therapy system.